A randomized, double-blind, placebo-controlled study assessing the safety and tolerability of regadenoson in subjects with asthma or chronic obstructive pulmonary disease

Overview of attention for article published in Journal of Nuclear Cardiology, April 2012

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (67th percentile)

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 70,354 followers.

Safety and tolerability of regadenoson (selective A2A receptor agonist) in subjects with asthma or COPD. Open access. http://t.co/6K2FLU8P

Safety and tolerability of regadenoson (selective A2A receptor agonist) in subjects with asthma or COPD. Open access. http://t.co/cAHvGuP2

Safety and tolerability of regadenoson (selective A2A receptor agonist) in subjects with asthma or COPD. Open access. http://t.co/sMlKNb6u

Safety and tolerability of regadenoson (selective A2A receptor agonist) in subjects with asthma or COPD. Open access. http://t.co/dkYUOwBp

RT @usmolecular: A randomized, double-blind, placebo-controlled study assessing the safety and tolerability o... http://t.co/rc4KP01M #molecularimaging

A randomized, double-blind, placebo-controlled study assessing the safety and tolerability o... http://t.co/rc4KP01M #molecularimaging